Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Pardes Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 31.0K | 0 | −31.0K (−100.0%) |
| Value | $66.7K | $0 | −$66.7K (−100.0%) |
New holders (0)
Institutions that held Pardes Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (1)
Institutions that held Pardes Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Barclays PLC | 31,037 | $66.7K |